Levels of metalloproteinase (MMP-3, MMP-9), NF-kB ligand (RANKL), and nitric oxide (NO) in peripheral blood of osteoarthritis (OA) patients

Clinical Laboratory

Volumn 58, Issue 7-8, 2012, Pages 755-762

  Li, Heng ^a   Li, Liqin ^b   Min, Jikang ^a   Yang, Honghang ^a   Xu, Xuchun ^a   Yuan, Yongjian ^a   Wang, Dan ^a  

^a HUZHOU UNIVERSITY   (China)

^b HUZHOU CENTRAL HOSPITAL   (China)

Author keywords

Matrix metalloproteinase 3; Matrix metalloproteinase 9; Nitric oxide; Osteoarthritis; Receptor activator of NF kB ligand

Indexed keywords

GELATINASE B; MESSENGER RNA; NITRIC OXIDE; OSTEOCLAST DIFFERENTIATION FACTOR; STROMELYSIN;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION; HUMAN; KNEE OSTEOARTHRITIS; LEQUESNE SCORE; MAJOR CLINICAL STUDY; MALE; PAIN ASSESSMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA; SCORING SYSTEM;

AGED; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NITRIC OXIDE; OSTEOARTHRITIS; RANK LIGAND; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84866115549     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2011.110823     Document Type: Article

References (30)

1. Hana H, Veronika B, Zdenek K, et al. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007;38:151-6.
2. Attur M, Dave M, Akamatsu M, et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 2002;10:1-4.
3. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.
4. Bastiaansen-Jenniskens Y, Koevoet W, De Bart A, et al. Contribution of collagen network features to functional properties of engineered cartilage. Osteoarthritis Cartilage 2008;16:359-66.
5. Bluteau G, Conrozier T, Mathieu P, et al. Matrix metalloproteinase-1, -3, -13 and aggrecanase-1 and -2 are differentially expressed in experimental osteoarthritis. Biochimica et Biophysica Acta 2001;1526:147-58.
6. Chu S, Yang S, Lue K, et al. Naproxen, meloxicam and methylprednisolone inhibit urokinase plasminogen activator and inhibitor and gelatinases expression during the early stage of osteoarthritis. Clinica Chimica Acta 2008;387:90-6.
7. Hsieh YS, Yang SF, Chu SC, et al. Expression changes of gelatinases in human osteoarthritic knees and arthroscopic debridement. Arthroscopy 2004;20:482-8.
8. Chu SC, Yang SF, Lue KH, et al. Regulation of gelatinases expression by cytokines, endotoxin, and pharmacological agents in the human osteoarthritic knee. Connective Tissue Research 2004;14:1237-47.
9. Takahashi M, Naito K, Abe M, et al. Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis. Arthritis Research Therapy 2004;6:208-12.
10. Abramson SB. Osteoarthritis and nitric oxide. Osteoarthritis Cartilage 2008;16 Suppl 2:S15-20.
11. Hashimoto S, Takahashi K, Amiel D, et al. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheumatism 2004;41:1266-74.
12. Botter SM, Van Osch GJ, Waarsing JH, et al. Cartilage damage pattern in relation to subchondral plate thickness in a collagenase-induced model of osteoarthritis. Osteoarthritis Cartilage 2008;16:506-14.
13. Schoppet M, Preissner KT, Hofbauer LC, et al. RANK ligand and osteoprotegerin paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol 2002;22:549-53.
14. Theill LE, Boyle WJ, Penninger JM, et al. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol 2002;20:795-823.
15. Mogi M, Otogoto J. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis. Arch Oral Biol 2007;52:894-8.
16. Nakashima T, Kobayashi Y, Yamasaki S, et al. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappa B ligand: modulation of the expression by osteotropic factors and cytokines. Biochem Biophys Res Commun 2000;275:768-75.
17. Pulsatelli L, Dolzani P, Silvestri T, et al. Soluble receptor activetor of nuclear factor-kB ligand (sRANKL)/osteoprotegerin balance in ageing and age-associated diseases. Biogerontology 2004;5:119-27.
18. Kellgren JH, Lawrence JS. Radiological assessment of osteoarthrosis. Ann Rheum Dis 1957;16:494-502.
19. Amoroso MG, Longobardo L. Real Time RT-PCR and flow cytometry to investigate wheat kernel hardness: role of puroindoline genes and proteins. Biotechnol Let 2004;26:1731-7.
20. Benito MJ, Veale DJ, Fitzgerald O, et al. Synovial tissue inflamemation in early and late osteoarthritis. Ann Rheum Dis 2005;64:1263-7.
21. Thomas CM, Fuller CJ, Whittles CE. Chondrocyte death by apoptosis is associated with cartilage matrix degradation. Osteoarthritis Cartilage 2007;15:27-34.
22. Henrotin YE, Sanchez C, Reginster JY, et al. The inhibition of metalloproteinase to treat osteoarthritis: reality and new perspectives. Expert Opin The Patents 2002;12:1-15.
23. Sanchez C, Mathy-Hartert M, Deberg MA, et al. Effects of rhein on human articular chondrocytes in alginate beads. Biochem Pharmacol 2003;65:377-88.
24. Shakibaei M, John T, Schulze-Tanzil G, et al. Suppression of NF-kB activation by curcumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondrocytes: Implications for the treatment of osteoarthritis. Biochem Pharmacol 2007;73:1434-45.
25. Nishida K, Doi T, Inoue H, et al. The role of nitric oxide in arthritic joints: a therapeutic target? Modem Rheumatol 2000;10:63-7.
26. Kobayashi K, Matsuzaka S, Yoshida Y, et al. The effects of intra-articularly injected sodium hyaluronate on levels of intact aggrecan and nitric oxide in the joint fluid of patients with knee osteoarthritis. Osteoarthritis Cartilage 2004;12:536-42.
27. Clancy R, Rediske J, Koehne C, et al. Activation of stress-activated protein kinase in osteoarthritic cartilage: evidence for nitric oxide dependence. Osteoarthritis Cartilage 2001;9:294-9.
28. Notoya K, Jovanovic DV, Reboul P, et al. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 2000;165:3402-10.
29. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology 2001;142:5050-5.
30. Khosla S, Arrighi HM, Melton LJ, et al. Correlates of osteoprotegerin levels in women and men. Osteoporos Int 2002;13:394-9.